Posted by SLS on April 26, 2016, at 21:51:41
In reply to Studies Cariprazine and Brexpiprazole, posted by Lamdage22 on April 26, 2016, at 9:31:03
> Hey Folks,
>
> i am still troubled by metabolic syndrome and i begin to worry. What i need is evidence, that Vraylar and Rexulti are less prone to weight gain and metabolic syndrome.I would like to know this also. I am getting itchy to try Vraylar.
Akathisia should be less common with Rexulti than with Vraylar or Abilify. However, it is important to know that Rexulti, like Abilify, is a partial agonist at dopamine receptors. Vraylar might be even more apt to produce akathisia than Abilify. I haven't seen enough people try Vraylar to know for sure.
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1088427
URL: http://www.dr-bob.org/babble/20160331/msgs/1088496.html